Press Releases

  • October 14, 2021
  • RadSite Announces First Wave of Cone Beam CT Imaging Accreditations
  • RadSite™, a leading accreditation organization promoting quality-based imaging practices, announced today that it has completed its first wave of accrediting Cone Beam CT imaging suppliers in the specialty areas of Dental, Maxillofacial, Orthopedics, and Podiatry. RadSite’s Dental and Medical Cone Beam CT Accreditation Programs were launched earlier this year after receiving recognition by the U.S. Centers for Medicare and Medicaid Services.

  • September 22, 2021
  • RadSite Announces Complimentary Fall Webinar Series
  • RadSite™, a leading accreditation organization promoting quality-based imaging practices, announced today its fall webinar series on updates to key accreditation standards. Starting on October 26, the monthly webinars address recent imaging trends covering RadSite Standards, reimbursement strategies, and leadership opportunities.

  • May 28, 2021
  • Center for Genomic Interpretation Launches ELEVATEGENETICS BRILLIANT Program
  • The Center for Genomic Interpretation (CGI) recently launched the ELEVATEGENETICS BRILLIANT™ Program. The innovative technical competency assessment is a game changer in evaluating the accuracy of genetic and genomic lab findings. The new program fills existing regulatory and accreditation gaps by assessing how well laboratory DNA sequencing tests can detect and rigorously classify important mutations and therapeutic biomarkers, especially in genetic sequences that are technically challenging. The dynamic CGI solution supports a wide range of stakeholders by helping ensure more accurate genetic/genomic testing and reporting, which improves the fidelity of patient treatment plans and promotes better clinical outcomes.

  • April 01, 2021
  • New Study Identifies Mental Health as a Risk Factor for COVID-19
  • The Population Health Impact Institute (PHII)™ announces a complimentary webinar, which will highlight how mental health conditions can increase the likelihood of COVID-19 infections. This innovative research study used Trajectory® Healthcare’s epidemiological-based AI software using the Colorado All Payer Claims Data Base to track how co-morbidities impact the likelihood of becoming infected with the coronavirus.

Scroll to Top